KANGHUA.KANGHUA, established in 1996, is a high-tech enterprise specializing in the fields of life sciences and precision medicine. Its business integrates the R&D, production, and sales of in vitro diagnostic reagents and testing analyzers with medical diagnostic services. The company's core business spans clinical testing equipment and in vitro diagnostic reagents, establishing six major product lines including POCT, immunodiagnostics, biochemical diagnostics, and molecular diagnostics. Its products are widely applied across diverse clinical scenarios such as infectious diseases, oncology, and cardiovascular disorders. After nearly three decades of development, KANGHUA has established a rigorous end-to-end quality management system and state-of-the-art production and R&D facilities. The company holds multiple authoritative certifications including NMPA and CE, with its technological R&D capabilities now ranking among the world's most advanced. KANGHUA enjoys a strong brand reputation and high customer trust within the industry.